Log in

MOTIF BIO PLC/S News Headlines (NASDAQ:MTFB)

$0.10
0.00 (0.00 %)
(As of 12/16/2019)
Add
Today's Range
$0.10
Now: $0.11
$0.12
50-Day Range
$0.11
MA: $0.11
$0.11
52-Week Range
$0.08
Now: $0.11
$11.50
Volume867,698 shs
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Headlines

MOTIF BIO PLC/S (NASDAQ MTFB) News Headlines

Source:
DateHeadline
Motif Bio And Hercules Amend Agreement To Facilitate Iclaprim SaleMotif Bio And Hercules Amend Agreement To Facilitate Iclaprim Sale
www.lse.co.uk - January 28 at 8:31 AM
Motif Bio PLCMotif Bio PLC
www.barrons.com - January 24 at 10:25 PM
What Kind Of Shareholder Owns Most Motif Bio plc (LON:MTFB) Stock?What Kind Of Shareholder Owns Most Motif Bio plc (LON:MTFB) Stock?
finance.yahoo.com - November 14 at 7:58 AM
Motif Bio Share News (MTFB)Motif Bio Share News (MTFB)
www.lse.co.uk - October 2 at 8:01 AM
Motif Bio To Become Cash Shell If Restructuring Proposals AcceptedMotif Bio To Become Cash Shell If Restructuring Proposals Accepted
www.lse.co.uk - October 1 at 5:00 PM
NIH to Evaluate Iclaprim Activity against ListeriaNIH to Evaluate Iclaprim Activity against Listeria
finance.yahoo.com - August 19 at 9:40 AM
Motif Bio and Hercules Capital Amend Loan and Security AgreementMotif Bio and Hercules Capital Amend Loan and Security Agreement
finance.yahoo.com - August 1 at 11:06 AM
Motif Bio Confirms Meeting Date with U.S. FDA regarding IclaprimMotif Bio Confirms Meeting Date with U.S. FDA regarding Iclaprim
finance.yahoo.com - July 26 at 11:12 AM
Motif Bio Confirms Receipt of Deficiency Notice from NasdaqMotif Bio Confirms Receipt of Deficiency Notice from Nasdaq
finance.yahoo.com - July 26 at 11:12 AM
Motif Bio down 5% after hours on delisting noticeMotif Bio down 5% after hours on delisting notice
seekingalpha.com - July 19 at 11:38 AM
Motif Bio Announces Receipt of Deficiency Notice from NasdaqMotif Bio Announces Receipt of Deficiency Notice from Nasdaq
finance.yahoo.com - July 19 at 11:38 AM
Motif Bio Submits Meeting Request and Package to the U.S. FDA for IclaprimMotif Bio Submits Meeting Request and Package to the U.S. FDA for Iclaprim
finance.yahoo.com - July 15 at 9:40 AM
Motif Bio Presents New Iclaprim Data at ASM Microbe 2019Motif Bio Presents New Iclaprim Data at ASM Microbe 2019
finance.yahoo.com - June 24 at 5:33 PM
Motif Bio to Evaluate Orphan Disease Opportunity for Iclaprim in OphthalmologyMotif Bio to Evaluate Orphan Disease Opportunity for Iclaprim in Ophthalmology
finance.yahoo.com - May 22 at 9:32 AM
Motif Bio plc AGM StatementMotif Bio plc AGM Statement
finance.yahoo.com - May 22 at 9:32 AM
Motif Bio Signs Agreement with Lamellar BiomedicalMotif Bio Signs Agreement with Lamellar Biomedical
finance.yahoo.com - May 1 at 9:28 AM
Motif Bio Announces Appointment of Andrew Powell to Board of DirectorsMotif Bio Announces Appointment of Andrew Powell to Board of Directors
finance.yahoo.com - April 26 at 9:34 AM
Motif Bio plc: Notice of Annual General MeetingMotif Bio plc: Notice of Annual General Meeting
finance.yahoo.com - April 26 at 9:34 AM
Motif Bio Presents New Iclaprim Data at ECCMID 2019Motif Bio Presents New Iclaprim Data at ECCMID 2019
finance.yahoo.com - April 16 at 10:29 AM
Motif Bio up 15% premarket ahead of Inclaprim presentationsMotif Bio up 15% premarket ahead of Inclaprim presentations
seekingalpha.com - April 4 at 9:45 AM
Motif Bio to Present Iclaprim Data at ECCMID 2019Motif Bio to Present Iclaprim Data at ECCMID 2019
finance.yahoo.com - April 4 at 9:45 AM
Motif Bio up 57% premarket on iclaprim meeting with FDAMotif Bio up 57% premarket on iclaprim meeting with FDA
seekingalpha.com - March 20 at 9:24 AM
Motif Bio Granted Meeting with U.S. FDA regarding IclaprimMotif Bio Granted Meeting with U.S. FDA regarding Iclaprim
finance.yahoo.com - March 20 at 9:24 AM
Motif Bio Announces Appointment of Bruce Williams as Interim Chairman and Resignation of Richard Morgan from the BoardMotif Bio Announces Appointment of Bruce Williams as Interim Chairman and Resignation of Richard Morgan from the Board
www.globenewswire.com - March 18 at 9:24 AM
Motif Bio Announces Appointment of Bruce Williams as Interim Chairman and Resignation of Richard Morgan from the BoardMotif Bio Announces Appointment of Bruce Williams as Interim Chairman and Resignation of Richard Morgan from the Board
finance.yahoo.com - March 18 at 9:24 AM
Motif Bio Conference Call and WebcastMotif Bio Conference Call and Webcast
finance.yahoo.com - February 19 at 10:02 AM
Motif BioSciences Enters into Amendment Agreement with Hercules CapitalMotif BioSciences Enters into Amendment Agreement with Hercules Capital
finance.yahoo.com - February 18 at 10:00 AM
Motif Bio Receives Complete Response Letter from the FDAMotif Bio Receives Complete Response Letter from the FDA
finance.yahoo.com - February 14 at 9:50 AM
This page was last updated on 2/16/2020 by MarketBeat.com Staff

Featured Article: Support Level

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel